Global Insulinoma Treatment Market 2019-2023 | Strategic Alliances to Drive Growth | Technavio

January 9, 2019

LONDON--(BUSINESS WIRE)--Jan 9, 2019-- analysts forecast the global insulinoma treatment market to grow at a CAGR of over 3% during the forecast period, according to their latest market research report.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190109005294/en/

Technavio has published a new market research report on the global insulinoma treatment market from 2019-2023. (Graphic: Business Wire)

Strategic alliances are one of the major trends being witnessed in the . Advances are being witnessed in insulinoma treatment due to the increasing awareness of neuroendocrine tumors and insulinoma. Most treatment options, including surgery and chemotherapy, are expensive. Many companies are collaborating with other organizations to develop and market treatments and therapies to share the cost as the cost involved in the entire drug development and commercialization cycle are quite high.

This report is available at a USD 1,000 discount for a limited time only:

According to Technavio analysts, one of the key factors contributing to the growth of the global insulinoma treatment market is the technological advances in surgery:

Global insulinoma treatment market: Technological advances in surgery

Insulinoma is caused by a small tumor in the pancreas that produces extra insulin. The pancreas stops producing insulin when blood sugar levels drop below the specified limits in healthy people. However, insulinomas continue producing insulin even when the blood sugar is considerably low. The best treatment for insulinoma among the available treatment options is the surgical removal of the tumor.

According to a senior research analyst at Technavio, “Laparoscopic surgery is being used for treating insulinoma owing to the recent developments in technology. Surgical advances play a major role in the growth of the global insulinoma treatment market as surgery is used as the first-line therapy for treatment.”

Global insulinoma treatment market: Segmentation analysis

The global insulinoma treatment market research report provides market segmentation by type (surgery, drugs, and other treatments) and by region (the Americas, EMEA, and APAC). It provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.

The surgery segment held the largest insulinoma treatment market share in 2018, accounting for over 64% of the market. This segment is expected to dominate the global market throughout the forecast period.

The Americas held the largest share of the market in 2018, followed by EMEA and APAC respectively. The Americas is expected to dominate the market throughout the period 2019-2023.

Looking for more information on this market?

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

Market ecosystem Market characteristics Market segmentation analysis

Market Sizing

Market definition Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

Regional comparison Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

Vendors covered Vendor classification Market positioning of vendors Competitive scenario

About Technavio

is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at .

View source version on businesswire.com:https://www.businesswire.com/news/home/20190109005294/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200




SOURCE: Technavio Research

Copyright Business Wire 2019.

PUB: 01/09/2019 04:26 AM/DISC: 01/09/2019 04:26 AM


Update hourly